By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Exosome Diagnostics 

1585 Broadway

New York  New York  10036  U.S.A.
Phone: n/a Fax: n/a



Company News
Exosome Diagnostics Announces Data Demonstrating ExoIntelliScore Prostate Accurately Predicted Gleason Score, Pathologic Stage And Tumor Volume In Patients With Prostate Cancer 10/1/2015 11:21:06 AM
Exosome Diagnostics Announces Publication Of ExoIntelliScore Prostate Initial Clinical Study Positive Results 9/21/2015 10:53:20 AM
Exosome Diagnostics Presents Clinical Performance Data For Exodx Lung(ALK) Liquid Biopsy Test And New Data On Detection Of EGFR Activating Mutations And T790M Resistance Mutation 9/9/2015 11:10:42 AM
Exosome Diagnostics Announces New Data Demonstrating Superior Ability To Isolate And Extract Highly Pure RNA From Serum And Plasma For Research Applications 9/3/2015 10:44:03 AM
Exosome Diagnostics Reels In $17.6 Million 9/2/2015 5:48:19 AM
Exosome Diagnostics Launches CLIA-Certified Laboratory In Cambridge, Mass. 8/12/2015 9:52:34 AM
Exosome Diagnostics Opens Up CLIA-Certified Lab in Cambridge, Massachusetts 8/12/2015 7:22:37 AM
Exosome Diagnostics Presents Data Demonstrating Ability To Detect EGFR Activating Mutations And T790M Resistance Mutation In Patients With Non-Small Cell Lung Cancer 8/5/2015 11:09:05 AM
ASCO15: Exosome Diagnostics Presents Data On Plasma-Based Solid Tumor Mutation Panel Liquid Biopsy Test, Demonstrates Excellent Analytical Performance For Detection Of Actionable Mutations Across Multiple Cancers 6/2/2015 11:19:52 AM
Exosome Diagnostics Announces Positive Results From Large Clinical Validation Study Of Prostate Cancer Liquid Biopsy 5/18/2015 10:32:18 AM